2.9.1. In Vitro Phosphorylation

MO Marta Orlicka-Płocka
AF Agnieszka Fedoruk-Wyszomirska
DG Dorota Gurda-Woźna
PP Paweł Pawelczak
PK Patrycja Krawczyk
MG Małgorzata Giel-Pietraszuk
GF Grzegorz Framski
TO Tomasz Ostrowski
EW Eliza Wyszko
request Request a Protocol
ask Ask a question
Favorite

Novel nucleoside analogues were evaluated as a substrate for adenosine kinase (ADK) in an in vitro phosphorylation assay (Precice ADK Assay Kit, NovoCIB, Lyon, France). The ADK-catalyzed phosphorylation reaction of 7-deazaKR and 8-azaKR was run for 30 min at 37 °C in a reaction buffer (100 mM Tris-HCl pH 8.5, 250 mM KCl, 10 mM MgCl2, 2.5 mM NAD, 2.75 mM ATP, IMPDH 20 mU/mL, and human recombinant ADK 2.2 mU/mL). The positive control of reaction efficiency was a phosphorylation reaction with 4 mM KR as a substrate, whereas, to inhibit reaction (negative control), 5-iodotubercidin (ADK inhibitor) was added to a final concentration of 500 µM. Phosphorylated products were separated and identified on fluorescent TLC Silica Gel 60 F254 plates (20 × 20 cm, Merck Millipore, Darmstadt, Germany) by using the following separation phase: ammonia/isopropanol/water (2:7:1 v/v). After resolution, the plates were dried, and the products were detected using the Gel Doc-it Imaging System (UVP, Upland, CA, USA). The phosphorylated products were quantified using Multi Gauge V3.0 (Fujifilm, Tokyo, Japan) software for Windows.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A